{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:29:47Z","timestamp":1774492187125,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.anai.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:13:18Z","timestamp":1434586398000},"page":"143-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Adverse reactions to infliximab and the outcome of desensitization"],"prefix":"10.1016","volume":"115","author":[{"given":"Ahmad A.","family":"Mourad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moheb N.","family":"Boktor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0625-9374","authenticated-orcid":false,"given":"Yesim","family":"Yilmaz-Demirdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami L.","family":"Bahna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2015.06.004_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5114\/aoms.2013.38670","article-title":"Tumor necrosis factor-\u03b1 antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis","volume":"9","author":"Kawalec","year":"2013","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.anai.2015.06.004_bib2","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.anai.2015.06.004_bib3","first-page":"1209","article-title":"Efficacy and adverse reactions of the TNF alpha inhibitor infliximab in rheumatoid arthritis","volume":"71","author":"Imagama","year":"2013","journal-title":"Nihon Rinsho"},{"issue":"suppl 3","key":"10.1016\/j.anai.2015.06.004_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2012.11208.x","article-title":"Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data","volume":"167","author":"Rustin","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2015.06.004_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","article-title":"The incidence and management of infusion reactions to infliximab: a large center experience","volume":"98","author":"Cheifetz","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"suppl 2","key":"10.1016\/j.anai.2015.06.004_bib6","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/s11739-011-0611-x","article-title":"Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction","volume":"7","author":"Vultaggio","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.anai.2015.06.004_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/cea.12098","article-title":"Allergological in\u00a0vitro and in\u00a0vivo evaluation of patients with hypersensitivity reactions to infliximab","volume":"43","author":"Matucci","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2015.06.004_bib8","doi-asserted-by":"crossref","unstructured":"Alvarez-Cuesta E, Madrigal-Burgaleta R, Angel-Pereira D, et\u00a0al. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization [published online ahead of print March 31, 2015]. Allergy. http:\/\/dx.doi.org\/10.1111\/all.12620.","DOI":"10.1111\/all.12620"},{"key":"10.1016\/j.anai.2015.06.004_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00054725-200102000-00005","article-title":"Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction","volume":"7","author":"Puchner","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.anai.2015.06.004_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2036.2006.03026.x","article-title":"Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions","volume":"24","author":"Duburque","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.anai.2015.06.004_bib11","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.06.004_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MIB.0b013e3182802ae1","article-title":"Elective switching from infliximab to adalimumab in stable Crohn's disease","volume":"19","author":"Hoentjen","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"suppl 2","key":"10.1016\/j.anai.2015.06.004_bib13","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy","volume":"125","author":"Khan","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.06.004_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","article-title":"Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease","volume":"348","author":"Baert","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.anai.2015.06.004_bib15","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1001\/jama.1997.03550220101014","article-title":"Allergic reactions to drugs and biologic agents","volume":"278","author":"deShazo","year":"1997","journal-title":"JAMA"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615003762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615003762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:13:31Z","timestamp":1761052411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120615003762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1081120615003762"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2015.06.004","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse reactions to infliximab and the outcome of desensitization","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}